iRiva Medical

Executive Summary

iRiva Medical is a private, venture-backed medical device company based in San Diego, California, focused on developing next-generation neuromodulation technology platforms to treat chronic diseases. Founded in 2018, the company combines implantable devices with drug delivery systems to address significant unmet clinical needs across large patient populations. iRiva's innovative approach targets conditions such as chronic pain, neurological disorders, and other complex diseases where traditional therapies are limited. By leveraging advanced neuromodulation techniques, the company aims to provide more effective, targeted, and less invasive treatment options. With a strong intellectual property portfolio and a dedicated team, iRiva is poised to disrupt the neuromodulation market and improve patient outcomes. While still in early development stages, the company's technology has the potential to address multi-billion-dollar markets, making it an attractive opportunity for strategic partnerships and investment. The company's progress and future milestones will be critical in determining its trajectory in the competitive medical device landscape.

Upcoming Catalysts (preview)

• TBDSeries B or C Funding Round70% success
• TBDFirst-in-Human Clinical Trial Initiation50% success
• TBDKey Strategic Partnership with Pharma or MedTech Company60% success